The notice includes a list of 14 specific treatments associated with common chronic conditions, such as insulin for people who have diabetes or SSRIs for people with depression. Previously, these services were not considered preventive, and people with high-deductible health plans had to pay out of pocket for them until they hit their deductible. However, cost barriers led many people to put off care, which often worsened their health conditions and led to the need for more extensive care down the line.
The IRS and Treasury Department chose services that were low-cost, had a significant impact on the health of someone with a chronic condition, and could prevent the need for higher-cost treatments. The agencies will review and update the list every five to 10 years.
The notice was issued to comply with a June 24 executive order from President Donald Trump calling for guidance on expanding high-deductible health plans with HSAs to cover low-cost preventive care for people with chronic conditions.
More articles on payer issues:
UnitedHealth records $3.3B profit in Q2
Admit or transfer? For children with mental health disorders, hospitals’ decision may rest on insurance
Kentucky lab owner admits to defrauding Humana, Aetna, Anthem
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
